InvestWiser

Real Heart

HEARTNasdaq StockholmHealthcareMarket value 133 m SEK
15.60SEK −1.9%
last day · Price as of 19 November 2026

The answer first

Does Real Heart beat the market?

No, Real Heart has not beaten the market over the last year.

Real Heart+9.1%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 17% of Nordic stocks

    • Quality48
    • Value10
    • Trend41

    No. 141 of 195 in healthcare

Max for seven days

Follow Real Heart with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Real Heart

From today, at a price of 15.60 SEK. Write why you follow Real Heart, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Real Heart

Your first answer is free, no account needed.

Do you own Real Heart, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Real Heart and a few more. Free, no card.

Past year against the exchange and Super Stock
Real Heart+9.1%Stockholm (OMXSGI)+17.6%Super Stock+46.4%
18 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Real Heart has risen 9.1% over the past year, including dividends.
  • Overall, Real Heart ranks better than 17% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 96.1%. The price is 99.1% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

17

Quality, value and trend together. Better than 17% of Nordic stocks.

No. 141 of 195 in healthcare

Quality48
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 133 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.04
  • Asset turnoverSales divided by everything the company owns0.00
  • Return on equityProfit divided by equity−43.8%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value10
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 136 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity1.4
  • P/SPrice divided by sales900.6
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend41
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 85 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−16.6%
  • 6 months−11.6%
  • 9 months+11.4%
  • 12 months+9.1%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−5.2%
3 years, per year
−21.9%
5 years, per year
−39.9%
10 years, per year
−28.3%
Largest fall, 3 years
−96.1%
From a peak to the bottom
From the peak now
−99.1%
How far the price is from the peak
Volatility, 1 year
49.4%
How much the price swings over a year
Beta, 1 year
−0.01
How much the price moves when the market moves

Return with dividends reinvested.

About Real Heart

Real Heart is a company in healthcare, listed on Nasdaq Stockholm. By market value, Real Heart is number 80 of 137 companies in healthcare on Nasdaq Stockholm. Real Heart has not paid a dividend in the past twelve months. Of the three measures in the ranking, Real Heart is strongest on quality, better than 48% of Nordic stocks. The share trades in SEK. It has around 18 employees.

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.

See the full analysis of Real Heart.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market